Events Partner Content STING & TLR Targeting Therapies Summit Investigating the cGAS-STING and TLR pathways
Views & Analysis CAR-Ts dominated the agenda at ASH 2017 The American Society for Hematology congress was dominated by CAR-T therapies – their potential new uses, how to manage safety issues and bring these costly cellular treatments to patients.
Partner Content Partner Content Exclusive Pfizer Speaker Interview Released Exclusive Pfizer Speaker Interview Released
Oncology Hernexeos and what’s next, with Vicky Brown At Reuters Pharma USA this week, Boehringer Ingelheim's Vicky Brown spoke with us about the company's recent approval for Hernexeos in NSCLC.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
